These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3856415)

  • 1. Myophosphorylase deficiency impairs muscle oxidative metabolism.
    Haller RG; Lewis SF; Cook JD; Blomqvist CG
    Ann Neurol; 1985 Feb; 17(2):196-9. PubMed ID: 3856415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease.
    Wagenmakers AJ; Coakley JH; Edwards RH
    Int J Sports Med; 1990 May; 11 Suppl 2():S101-13. PubMed ID: 2193889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies.
    Chaussain M; Camus F; Defoligny C; Eymard B; Fardeau M
    Eur J Med; 1992 Dec; 1(8):457-63. PubMed ID: 1341204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic control of cardiac output response to exercise in McArdle's disease.
    Lewis SF; Haller RG; Cook JD; Blomqvist CG
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Dec; 57(6):1749-53. PubMed ID: 6595253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [McArdle's disease. Apropos of a case].
    Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
    Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen consumption is increased relative to work rate in patients with McArdle's disease.
    O'Dochartaigh CS; Ong HY; Lovell SM; Riley MS; Patterson VH; Young IS; Nicholls DP
    Eur J Clin Invest; 2004 Nov; 34(11):731-7. PubMed ID: 15530145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue.
    Lewis SF; Haller RG
    J Appl Physiol (1985); 1986 Aug; 61(2):391-401. PubMed ID: 3528113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
    Vissing J; Haller RG
    N Engl J Med; 2003 Dec; 349(26):2503-9. PubMed ID: 14695410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerobic conditioning: an effective therapy in McArdle's disease.
    Haller RG; Wyrick P; Taivassalo T; Vissing J
    Ann Neurol; 2006 Jun; 59(6):922-8. PubMed ID: 16718692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency.
    Haller RG; Lewis SF
    N Engl J Med; 1991 Feb; 324(6):364-9. PubMed ID: 1824792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
    Brooke MH; Patterson VH; Kaiser KK
    Muscle Nerve; 1983; 6(3):204-6. PubMed ID: 6574314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
    Vissing J; Duno M; Schwartz M; Haller RG
    Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).
    Tsujino S; Shanske S; DiMauro S
    N Engl J Med; 1993 Jul; 329(4):241-5. PubMed ID: 8316268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?
    Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J
    Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnostic cycle test for McArdle's disease.
    Vissing J; Haller RG
    Ann Neurol; 2003 Oct; 54(4):539-42. PubMed ID: 14520671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise.
    Jehenson P; Leroy-Willig A; de Kerviler E; Duboc D; Syrota A
    AJR Am J Roentgenol; 1993 Aug; 161(2):347-51. PubMed ID: 8333376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal ventilation during exercise in McArdle's syndrome: modulation by substrate availability.
    Haller RG; Lewis SF
    Neurology; 1986 May; 36(5):716-9. PubMed ID: 3458030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise tolerance and daily life in McArdle's disease.
    Ollivier K; Hogrel JY; Gomez-Merino D; Romero NB; Laforêt P; Eymard B; Portero P
    Muscle Nerve; 2005 May; 31(5):637-41. PubMed ID: 15614801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased muscular beta-hydroxyacyl CoA dehydrogenase with McArdle's disease.
    Turk WR; Heller SL; Norris BJ; Nemeth PM
    Muscle Nerve; 1990 Jul; 13(7):607-12. PubMed ID: 2388659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.